8551 - 8575 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 417End Page: 421Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26483Citation Count: 41
-
OPENTitle: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) DimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 11Start Page: 1971End Page: 1980Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259Citation Count: 17
-
OPENTitle: The ZFHX3 GGC Repeat Expansion Underlying Spinocerebellar Ataxia Type 4 has a Common Ancestral FounderJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.30077Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30077Citation Count: 1
-
OPENTitle: Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association StudyJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30054Best OA location URL: https://doi.org/10.1002/mds.30054Citation Count: 3
-
RESTRICTEDTitle: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490Citation Count: 7
-
RESTRICTEDTitle: Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 1Start Page: 688End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1109-6Citation Count: 56
-
OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 11
-
OPENTitle: Relationships between neuropsychiatric symptoms, subtypes of astrocyte activities, and brain pathologies in Alzheimer's disease and Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.70242Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70242Citation Count: 0
-
OPENTitle: Genome-wide association study of REM sleep behavior disorder in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01078-wBest OA location URL: https://www.nature.com/articles/s41531-025-01078-w.pdfCitation Count: 0
-
OPENTitle: Nicotinamide-N-methyltransferase controls behavior, neurodegeneration and lifespan by regulating neuronal autophagyJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 9Start Page: e1007561End Page: e1007561Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1007561Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1007561&type=printableCitation Count: 39
-
RESTRICTEDTitle: Targeting the Dopaminergic System in AutoimmunityJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 57End Page: 73Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5Citation Count: 72
-
RESTRICTEDTitle: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse modelsJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251Best OA location URL: https://doi.org/10.1016/j.omtn.2024.102251Citation Count: 3
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 79
- Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial2024OPENTitle: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100248End Page: 100248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248Best OA location URL: http://dx.doi.org/10.1016/j.prdoa.2024.100248Citation Count: 0
-
OPENTitle: Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 6Start Page: 3130End Page: 3130Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25063130Best OA location URL: https://www.mdpi.com/1422-0067/25/6/3130/pdf?version=1709891329Citation Count: 5
-
RESTRICTEDTitle: Intra-arterial bone marrow mononuclear cells for strokeJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 2Start Page: 105End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00005-4Citation Count: 1
-
RESTRICTEDTitle: What matters to people with Parkinson’s disease living in Australia?Journal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 22Issue #: 2Start Page: 338End Page: 341Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2014.06.097Citation Count: 10
-
OPENTitle: Effect of augmenting cholinergic function on gait and balanceJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-015-0523-xBest OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-015-0523-xCitation Count: 25
-
OPENTitle: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotypeJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 30Issue #: 4Start Page: 1465End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021Best OA location URL: http://www.cell.com/article/S1525001622000211/pdfCitation Count: 15
-
OPENTitle: Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brainJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00579-wBest OA location URL: https://www.nature.com/articles/s41531-023-00579-w.pdfCitation Count: 9
- A Comparative Photophysical Study of Structural Modifications of Thioflavin T-Inspired Fluorophores2020OPENTitle: A Comparative Photophysical Study of Structural Modifications of Thioflavin T-Inspired FluorophoresJournal Name: The Journal of Physical Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 11Issue #: 19Start Page: 8406End Page: 8416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jpclett.0c01549Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8741274Citation Count: 25
-
OPENTitle: LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00354-3Best OA location URL: https://www.nature.com/articles/s41531-022-00354-3.pdfCitation Count: 36
-
OPENTitle: Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter studyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 1Start Page: 91End Page: 102Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13386Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13386Citation Count: 29
-
OPENTitle: Decreased vestibular efficacy contributes to abnormal balance in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 440Issue #:Start Page: 120357End Page: 120357Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120357Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9444904Citation Count: 13
-
OPENTitle: GDNF signaling in subjects with minimal motor deficits and Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 153Issue #:Start Page: 105298End Page: 105298Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105298Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105298Citation Count: 24